165 related articles for article (PubMed ID: 37740194)
1. Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression.
Liu T; Fan MQ; Xie XX; Shu QP; Du XH; Qi LZ; Zhang XD; Zhang MH; Shan G; Du RL; Li SZ
J Transl Med; 2023 Sep; 21(1):656. PubMed ID: 37740194
[TBL] [Abstract][Full Text] [Related]
2. UCHL3 induces radiation resistance and acquisition of mesenchymal phenotypes by deubiquitinating POLD4 in glioma stem cells.
Fan L; You H; Jiang X; Niu Y; Chen Z; Wang H; Xu Y; Zhou P; Wei L; Jiang T; Deng D; Xue L; Peng Y; Xing W; Shao N
Cell Mol Life Sci; 2024 Jun; 81(1):247. PubMed ID: 38829550
[TBL] [Abstract][Full Text] [Related]
3. UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization.
Song Z; Li J; Zhang L; Deng J; Fang Z; Xiang X; Xiong J
Am J Cancer Res; 2019; 9(9):1970-1981. PubMed ID: 31598398
[TBL] [Abstract][Full Text] [Related]
4. UCHL3 promotes proliferation of colorectal cancer cells by regulating SOX12 via AKT/mTOR signaling pathway.
Li J; Zheng Y; Li X; Dong X; Chen W; Guan Z; Zhang C
Am J Transl Res; 2020; 12(10):6445-6454. PubMed ID: 33194042
[TBL] [Abstract][Full Text] [Related]
5. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.
Chen M; Li L; Zheng PS
Cancer Sci; 2019 Sep; 110(9):2794-2805. PubMed ID: 31336010
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/β-catenin signalling pathway.
Yuan H; Yu S; Cui Y; Men C; Yang D; Gao Z; Zhu Z; Wu J
J Cell Mol Med; 2017 Dec; 21(12):3254-3263. PubMed ID: 28631286
[TBL] [Abstract][Full Text] [Related]
7. PHB promotes bladder cancer cell epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
Jiang LJ; Guo SB; Huang ZY; Li XL; Jin XH; Huang WJ; Tian XP
Pathol Res Pract; 2023 Jul; 247():154536. PubMed ID: 37235908
[TBL] [Abstract][Full Text] [Related]
8. UCHL-3 as a potential biomarker of ovarian cancer.
Yang Q; Peng X; Nian Z; Yuan S; Wang Z; Song Y; Shamsnur R; Wang H; Yi T
Gynecol Oncol; 2024 Mar; 182():156-167. PubMed ID: 38266402
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA PEG10 facilitates bladder cancer cells proliferation, migration, and invasion via repressing microRNA-29b.
Liang T; Wang Y; Wang Y; Wang Y
J Cell Physiol; 2019 Nov; 234(11):19740-19749. PubMed ID: 30941768
[TBL] [Abstract][Full Text] [Related]
11. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
12. CIRP promotes the progression of non-small cell lung cancer through activation of Wnt/β-catenin signaling via CTNNB1.
Liao Y; Feng J; Sun W; Wu C; Li J; Jing T; Liang Y; Qian Y; Liu W; Wang H
J Exp Clin Cancer Res; 2021 Aug; 40(1):275. PubMed ID: 34465343
[TBL] [Abstract][Full Text] [Related]
13. MGAT1 is a novel transcriptional target of Wnt/β-catenin signaling pathway.
Akiva I; Birgül Iyison N
BMC Cancer; 2018 Jan; 18(1):60. PubMed ID: 29310626
[TBL] [Abstract][Full Text] [Related]
14. Super-enhancer-associated SNHG15 cooperating with FOSL1 contributes to bladder cancer progression through the WNT pathway.
Tan M; Pan Q; Gong H; Zhai X; Wan Z; Ge M; Gu J; Zhang D; Chen X; Xu D
Pharmacol Res; 2023 Nov; 197():106940. PubMed ID: 37758102
[TBL] [Abstract][Full Text] [Related]
15. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of lncRNA SNHG7 inhibited cell proliferation and migration in bladder cancer through activating Wnt/β-catenin pathway.
Chen Y; Peng Y; Xu Z; Ge B; Xiang X; Zhang T; Gao L; Shi H; Wang C; Huang J
Pathol Res Pract; 2019 Feb; 215(2):302-307. PubMed ID: 30527358
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-specific protease 15 contributes to gastric cancer progression by regulating the Wnt/β-catenin signaling pathway.
Zhong M; Zhou L; Fang Z; Yao YY; Zou JP; Xiong JP; Xiang XJ; Deng J
World J Gastroenterol; 2021 Jul; 27(26):4221-4235. PubMed ID: 34326621
[TBL] [Abstract][Full Text] [Related]
18. GSK3β and UCHL3 govern RIPK4 homeostasis via deubiquitination to enhance tumor metastasis in ovarian cancer.
Shan W; Peng W; Chen Y; Wang Y; Yu Q; Tian Y; Dou Y; Tu J; Huang X; Li X; Wang Z; Zhu Q; Chen J; Xia B
Oncogene; 2024 Jun; 43(25):1885-1899. PubMed ID: 38664501
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
[TBL] [Abstract][Full Text] [Related]
20. LINC00665 activates Wnt/β-catenin signaling pathway to facilitate tumor progression of colorectal cancer via upregulating CTNNB1.
Han T; Gao M; Wang X; Li W; Zhuo J; Qu Z; Chen Y
Exp Mol Pathol; 2021 Jun; 120():104639. PubMed ID: 33865827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
